Skip to main content
TipRanks
Go Ultimate75% OFF

KP Tissue (KPT) Stock Statistics & Valuation Metrics

112 Followers

Total Valuation

KP Tissue has a market cap or net worth of CAD 124.40M. The enterprise value is CAD 121.99M.

Market Cap
CAD 124.40M
Enterprise Value
CAD 121.99M

Share Statistics

KP Tissue has 10,032,387 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
10,032,387
Owned by Insiders
0.50%
Owned by Institutions
3.19%

Financial Efficiency

KP Tissue’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 0.00%.

Return on Equity (ROE)
0.12
Return on Assets (ROA)
0.12
Return on Invested Capital (ROIC)
0.00%
Return on Capital Employed (ROCE)
0.00
Revenue Per Employee
0
Profits Per Employee
3,149.63
Employee Count
2,700
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of KP Tissue is 13.76. KP Tissue’s PEG ratio is 0.07.

PE Ratio
13.76
PS Ratio
0.00
PB Ratio
1.73
Price to FCF
0.00
Price to Operating Cash Flow
0.00
PEG Ratio
0.07

Income Statement

In the last 12 months, KP Tissue had revenue of 0 and earned 8.50M in profits. Earnings per share was 0.85.

Revenue
0
Gross Profit
0
Operating Income
0
Pretax Income
8.50M
Net Income
8.50M
EBITDA
318.23M
Earnings Per Share (EPS)
0.85

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
0.00

Dividends & Yields

KP Tissue pays an annual dividend of CAD 0.21, resulting in a dividend yield of 6.37%

Dividend Per Share
CAD 0.21
Dividend Yield
6.37%
Payout Ratio
N/A
Free Cash Flow Yield
0.00%
Earnings Yield
7.28%

Stock Price Statistics

Beta
0.36
52-Week Price Change
28.95%
50-Day Moving Average
12.09
200-Day Moving Average
11.71
Relative Strength Index (RSI)
57.46
Average Volume (3m)
15.97K

Important Dates

KP Tissue upcoming earnings date is Mar 11, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 11, 2026
Next Earnings Date
Mar 11, 2027
Ex-Dividend Date
Jun 30, 2026

Financial Position

KP Tissue as a current ratio of 1.00, with Debt / Equity ratio of 0.00%

Current Ratio
1.00
Quick Ratio
1.00
Debt to Market Cap
0.00
Net Debt to EBITDA
0.00
Interest Coverage Ratio
0.00

Taxes

In the past 12 months, KP Tissue has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

KP Tissue EV to EBITDA ratio is 0.72, with an EV/FCF ratio of 0.00.

EV to Sales
0.00
EV to EBITDA
0.72
EV to Free Cash Flow
0.00
EV to Operating Cash Flow
0.00

Balance Sheet

KP Tissue has CAD 0.00 in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of CAD 0.00 billion.

Cash & Marketable Securities
CAD 0.00
Total Debt
CAD 0.00
Net Cash
CAD 0.00
Net Cash Per Share
CAD 0.00
Tangible Book Value Per Share
CAD 7.09

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for KP Tissue is CAD 13.00, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target
CAD 13.00
Price Target Upside
6.12% Upside
Analyst Consensus
Neutral
Analyst Count
1
Revenue Growth Forecast
―
EPS Growth Forecast
165.83%

Scores

Smart Score
8
AI Score
56